In humans, heterozygous mutation of OPA1 accounts for approximately 60% of all autosomal dominant optic atrophy (DOA) cases, which have an estimated minimum prevalence of 1 in 25 000 [233]. Here, OPA1 is linked to autosomal dominant optic atrophy.